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rectum during treatment for prostate immobilization, which 
positioned the imbedded detectors in direct contact with the anterior 
rectal wall. Prior to treatment, patients were scanned on the 
treatment couch of a CT-on-rails Linear Accelerator, which allowed 
precise localization of the detectors. During the patient treatment, 
dose information was collected and displayed in real time, providing a 
visual measure of dose rate and cumulative dose as a function of time. 
Patient treatment was re-planned with the two detectors contoured 
on the new CT dataset to calculate the expected cumulative dose to 
the detectors for that corresponding fraction. The daily recalculated 
dose was compared to the measurement of the delivered dose for the 
corresponding fraction. 
Results: The average deviation between the measured dose and the 
treatment planning system calculated dose over the 58 measurements 
after removing 5 outliers was -1.5% with a standard deviation of 4.0%. 
The minimum deviation observed was 0.26% (calculated dose: 191.8 
cGy, measured dose: 191.3 cGy). The maximum observed deviation for 
a detector positioned in contact with the anterior rectal wall was -
8.1% (184.7 cGy versus 169.7 cGy) which could indicate organ motion. 
Patient in-vivo results are displayed in Table 1 with in-phantom results 
for comparison. Daily in-vivo results for patient number 2 are 
displayed in Figure 1. Due to the real time nature of this detector it 
was also possible to distinguish the dose delivered by individual beams 
during treatment. 
 
 
 
Conclusions: This PSD system has proved to be an excellent in-vivo 
dosimeter, capable of measuring dose received by a patient with high 
accuracy as treatment is being delivered. This permits daily 
monitoring of the dose received by patients. The detector has the 
potential to detect internal organ motion and is certainly capable of 
alerting users if the patient is not set up properly on the basis of 
larger dose deviations (20% or above). Additionally, the detector is 
non invasive, and can be implemented with no alteration of current 
treatment practices.  
   
PO-0880   
Voluntary deep inspiration breath hold for locally advanced lung 
cancer radiotherapy is feasible and reproducible 
M. Josipovic1, S. Damkjær1, K. Håkansson1, M. Aznar1, J.P. 
Bangsgaard1, G. Westman1, G. Fredberg Persson1 
1The Finsen Center - Rigshospitalet, Radiation Oncology, Copenhagen, 
Denmark  
 
Purpose/Objective: Radiotherapy (RT) of advanced non-small cell 
lung cancer (NSCLC) results in poor survival and high risk of lung 
toxicity. Radiotherapy in deep inspiration breath hold (DIBH) may 
reduce lung toxicity as lung volume increases. Prior to clinical 
implementation, evaluation of voluntary DIBH feasibility and 
reproducibility is necessary, since NSCLC patients often have poor 
lung function, which can further impair during a RT course. 
Materials and Methods: Nine patients were included in the study so 
far (six declined). Besides standard imaging for RT planning (4D 
computed tomography (CT) and DIBH CT), all patients had three 
additional imaging sessions including three consecutive DIBH CT at 
treatment fractions 2, 16 and 31. All DIBHs were visually guided. An 
optical marker based system was used for respiratory monitoring, 
enabling comfortable voluntary DIBH. Gating window of 2-3 mm was 
chosen at individual level, adjusted to each patient's performance, 
when coaching prior to RT planning. The patients' capability to 
increase lung volume and to perform repeated DIBH lasting 20 seconds 
or more throughout the RT course was considered a measure of 
feasibility. The reproducibility of DIBH level was evaluated as intra- 
and inter-fractional variations in DIBH lung volume and intra-
fractional changes in tumour position. As changes in tumour position 
were evaluated by manual registrations, intra-observer uncertainty of 
the registration process was evaluated as well. 
Results: Lung volume increased with DIBH compared to free breathing 
by 60% (range 35-87%; p < 0.0001; paired t-test). There was a slight 
non-significant trend (p=0.23; paired t-test) towards an increased lung 
volume at DIBH between the planning CT and the treatment days' DIBH 
CTs: 4% ± 6% (mean ± SD). No further variations in lung volume were 
observed throughout the treatment course: changes on days 16 & 31 
compared to day 2 were 0% ± 3%. Intra-fractional changes in lung 
volume were small, 1.1%± 0.8%. Intra-observer uncertainty in tumour 
registration was small, 0.2 mm ± 0.6mm three-dimensionally (3D). 
Intra-fractional changes in 3D tumour position were 2.1 mm ± 1.4 mm. 
No trend was observed throughout the course. Intra-fractional 3D 
tumour position change exceeded 3 mm in two DIBH CT sets, one 
patient suffered pneumonia at the time, the other patient had a 2 mm 
difference in chest excursion between the DIBHs on the particular 
day. The patients, who refused to enter the protocol (6/15) were on 
average 10 years older (p=0.014; t-test), which could be a potential 
bias of the study. 
Conclusions: DIBH seems feasible and reproducible intra- and inter-
fractionally during a course of NSCLC RT and is well tolerated. We are 
continuously accruing more patients in the protocol in order to 
strengthen these encouraging first results on stability and 
reproducibility of visually guided DIBH with external optical system for 
respiratory monitoring. 
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Purpose/Objective: The aim of the study was to increase total 
marrow irradiation (TMI) treatment effectiveness and time efficiency 
while minimizing the dose for non-skeletal structures. 
Materials and Methods: Twelve patients with multiple myeloma were 
treated by the following TMI method. As a target, all skeletal bones 
were contoured (Eclipse, Varian Inc.) excluding hand bones, jawbone, 
mandible and ethmoid bone. Critical organs were contoured for 
conformal avoidance. Due to the limitation in the longitudinal couch 
travel (effectively up to 135 cm), the total marrow irradiation delivery 
had to be split into two independent plans: HFS and FFS patient 
orientation. To avoid an unnecessary second CT scan, the FFS CT 
volume was generated by flipping the original HFS CT volume with our 
in-house written software. The upper body TMI plan (UTMI) covered 
the body from the head to 11 cm above knee joint, for which the 
helical tomotherapy technique was applied. The lower body TMI plan 
(LTMI) covered the body from the feet up to 6 cm below the knee 
joint, for which the direct tomotherapy technique was applied (two 
opposite fields of 90°-270°). All plans were implemented using the 
TomoHD treatment planning system (version 1.02; Accuray Inc.). The 
optimization goal was to achieve that a minimum of 85% of the target 
volume receives at least 99% of the prescription dose (12 Gy). 
Fractionation scheme was 3 x 4 Gy (three consecutive days, one 
irradiation a day). 
Results: In twelve patients, the following mean doses were obtained 
[mean±SD, Gy]: UTMI-target 12.15±0.06; LTMI-target 12.35±0.08; brain 
7.64±0.32; lenses 2.24±0.28; oral cavity 4.79±0.49; lungs 7.98±0.11; 
heart 7.51±0.29; liver 7.91±0.40; kidneys 6.46±0.27; bowel 7.51±0.26; 
bladder 6.53±0.15. Mean irradiation time [mean±SD, minutes] for 
UTMI was 35.15±3.50, and for LTMI was 12.66±0.79 (Fig.1). 
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Conclusions: Applying the described hypofractionated TMI (4 Gy dose 
per fraction) a dose reduction to the organs at risk ranged from 
18.67%-66.48% of the prescribed dose and the effective time for one 
radiation session was 1 hour and 15 minutes (including patient 
positioning and imaging). The tomotherapy direct field angles 
arrangement instead of using the helical intensity-modulated radiation 
has allowed minimizing the delivery error associated with the setup of 
the leg positioning, especially in horizontal direction. An additional 
benefit was the shorter irradiation time. A disadvantage of the direct 
technique was poor conformality, as a result of which the non-skeletal 
structures in legs (mostly muscles and vessels) received a higher dose 
in order to ensure hitting the target. In conclusion, the applied 4 Gy 
fractionation is feasible using TomoHD system and time-efficient in a 
busy radiotherapy department, requiring only a single patient setup a 
day on three consecutive days. Through hypofractionation, the 
biological equivalent dose is also effectively increased. Further 
observation of patients treated with this scheme is necessary to 
evaluate the treatment response. 
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Purpose/Objective: Data from the National Radiotherapy 
Implementation Group (NRIG) suggests that the provision of IMRT has 
improved from around 2% of patients in 2008 to around an estimated 
15% in 2012 (Cooper and Williams 2012). The objective of this survey 
was to determine how each centre currently carries out the quality 
assurance (QA) processes for these IMRT treatments. For the purposes 
of this survey IMRT is defined as inverse planned treatments and 
includes linac based, Tomotherapy and Cyberknife delivery. The aim 
was to collect information on equipment, approach and tolerances as 
well as how QA approaches may change in the future. 
Materials and Methods: The survey was web based, however a word 
version was also available. Questions were divided into the following 
categories: Background and equipment, machine tolerance and QA, 
machine based verification, software based verification, future plans. 
Results: 57 responses were received from 53 centres (4 centres 
answered separately for different systems). All centres use 6MV with 
27% also using 8, 10 or 15MV. 41% use dynamic delivery, 48% use step 
and shoot and 35% use VMAT with 11% using Tomotherapy. 82% are 
limiting the numbers they treat with 45% receiving extra funding for 
IMRT. 42% have developed their own tests for commissioning and QA. 
100% perform machine based measurements to check IMRT plans with 
66% measuring both point doses and dose distributions and the main 
burden falling on physics staff (94%). 74% perform machine based 
measurements for every patient, and 49% have changed their plan 
based on the results of the QA measurements. 63% perform software 
based calculations to check IMRT plans, with 88% being point doses, 
3% being dose distributions only and 9% being both. However 97% have 
never changed a plan based on the results of the calculated IMRT 
check. 73% of these calculations are performed by physicists with the 
remaining being undertaken by dosimetrists. 87% report that they 
intend to change their QA processes in the near future with 41% being 
who does the QA, 51% changing to a different measurement, 56% 
reducing the number of measurements and 41% stopping doing 
measurements altogether. 
Conclusions: All centres currently include machine based 
measurements in their QA processes. This is time consuming, taking 
up to 30 minutes per patient, even when batched. The majority have 
already started looking at other techniques and the trend is towards 
reduction of measurements and sharing of workload. 
   
PO-0883   
Light ions particle therapy with cost-effective new tools 
C. Nordin1, B. Nordin1, Y. Kumata2, L. Weber3, N. Tanizaki2 
1LIONESS Light Ions, R&D, Stockholm, Sweden  
2SUMITOMO Heavy Industries, Quantum Division, Tokyo, Japan  
3Lund University Hospital, Medical Physics, Lund, Sweden  
 
Purpose/Objective: Proton Therapy and Carbon Ion Therapy have 
shown very good and promising results for a number of indications. 
The synchrotrons used to date to accelerate light ions up to carbon 
are however very large and expensive. We have therefore developed 
efficient, compact, cost effective treatment units that can make light 
ions treatments available with less complexity and lower costs, for the 
benefit of more patients. The systems allow for five different light 
ions species for research and clinical use. There is promising potential 
in mixing light ions but to date a lack of facilities hinder such 
research.  
Materials and Methods: A new compact superconducting isochronous 
multiple-light-ion cyclotron has been designed by Sumitomo for 
Hydrogen (Protons), Helium Ions, Lithium Ions, Boron and Carbon Ions. 
The peak energy is >300 MeV/u and the maximum Boron range is 
about 26 cm. (≈20cm Carbon). In mixed-modality radiation therapy it 
is possible to simultaneously create a uniform distribution of 
biological effect, dose and radiation quality in the tumor volume. For 
instance, with Lithium in combination with Boron or Carbon ions, the 
Lithium ions are mainly used in the distal tumor region whereas Boron 
or Carbon ions are used closer to the patient surface. By this method 
the low LET plateau dose from Lithium is elevated significantly by 
Bragg peak Boron or Carbon ion dose delivery in the shallow tumor 
region. Pencil Beam Scanning delivery is used exclusively for maximum 
dose conformity to target volumes and minimized exposure to 
surrounding tissues and OAR.  
Results: An innovative layout and arrangement of treatment rooms 
and the relatively compact new cyclotron accelerator allows a 
significant cost reduction compared to previously built carbon ion 
treatment facilities such as HIMAC at NIRS in Chiba, Japan, HIT in 
Heidelberg, Germany and CNAO in Pavia, Italy. The overall facility 
cost and cost per Light Ions treatment room is less than the current 
market prices of proton-only facilities. High dose rates from the 
cyclotron, fast switching and continous line scanning as opposed to 
synchrotrons' intermittent beam and spot scanning techniques allow 
for shorter irradiation times and higher patient throughput. 
 Conclusions: The new light ions technology provides a compact and 
very efficient system for curative treatment of several common 
malignant tumors of:head and neck, lung, liver, prostate, bone/soft-
tissue sarcoma, cervix, and pelvis (Tsujii 2010). At a facility cost equal 
or less than today's proton-only facilities, combined with enhanced 
throughput, the cost per treatment is reduced.  
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Purpose/Objective: Stereotactic radiosurgery using frame-based 
positioning is a well-established technique for the treatment of benign 
and malignant lesions. By contrast, a new trend towards frameless 
systems using image-guided positioning techniques is gaining 
mainstream acceptance. This study was designed to compare the 
overall accuracy of the frameless with the frame-based radiosurgery 
technique and to evaluate the immobilization characteristics of a 
commercially available frameless mask, more specifically, the setup 
errors and the intrafraction motion, to the invasive fixation of the 
frame-based technique. 
Materials and Methods: Multiple hidden target tests(HTT) were 
performed to measure the overall accuracy of the two positioning 
techniques for radiosurgery (i.e. frameless using stereoscopicx-ray 
imaging and 6DOF registration/positioning and frame-based using 
invasive ring and localizer box). Forty patients with 66 brain 
metastases were enrolled for frameless stereotactic radiosurgery using 
X-ray imaging and a 6DOF robotic couch. To analyze the frameless 
characteristics positioning results were collected before and after 
treatment to assess patient setup error and intrafraction motion. The 
obtained data was bench marked to literature for comparison with 
frame-based techniques. 
